Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Steffen BT, Tang W, Lutsey PL, et al. "Proteomic analysis of diabetes genetic risk scores identifies complement C2 and neuropilin-2 as predictors of type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) Study." Diabetologia. 2022.
Steffen BT, Pankow JS, Lutsey PL, et al. "Proteomic profiling identifies novel proteins for genetic risk of severe COVID-19: the Atherosclerosis Risk in Communities Study." Hum Mol Genet. 2022;31(14):2452-2461.
Norby FL, Tang W, Pankow JS, et al. "Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study)." Am J Cardiol. 2021;161:42-50.
Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh JJ. "Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease." JAMA Intern Med. 2016;176(2):238-46.
Rooney MR, Bell EJ, Alonso A, et al. "Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases: The Atherosclerosis Risk in Communities (ARIC) Study." J Clin Gastroenterol. 2021;55(8):677-683.
Kritchevsky SB, Tell GS, Shimakawa T, et al. "Provitamin A carotenoid intake and carotid artery plaques: the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 1998;68(3):726-33.
Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Wu KK, Boerwinkle E. "P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study." Atherosclerosis. 2006;186(1):74-9.
Beyhaghi H, Reeve BB, Rodgers JE. "Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants." Value Health. 2016;19(8):996-1001.
Honda Y, Mok Y, Mathews L, et al. "Psychosocial factors and subsequent risk of hospitalizations with peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2021;329:36-43.
Turcot V, Lu Y, Highland HM, et al. "Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity." Nat Genet. 2019;51(7):1191-1192.
Lee M, Huan T, McCartney DL, et al. "Pulmonary Function and Blood DNA Methylation: A Multiancestry Epigenome-Wide Association Meta-analysis." Am J Respir Crit Care Med. 2022;206(3):321-336.
Charles LE, Burchfiel CM, Andrew ME, Gu JK, Petrini MF, Butler KR. "Pulmonary function and left ventricular mass in African Americans: the Atherosclerosis Risk in Communities (ARIC) study." Echocardiography. 2012;29(2):131-9.
Teramoto K, Santos M, Claggett B, et al. "Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis." PLoS Med. 2020;17(10):e1003361.
Luoto R, A Sharrett R, Eigenbrodt M, Arnett D. "Pulse pressure and age at menopause." BMC Womens Health. 2002;2(1):6.
Magnani JW, Zhu L, Norby FL, et al. "P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study." Am Heart J. 2015;169(1):53-61.e1.
Mandyam MC, Soliman EZ, Alonso A, et al. "The QT interval and risk of incident atrial fibrillation." Heart Rhythm. 2013;10(10):1562-8.
Winkler TW, Day FR, Croteau-Chonka DC, et al. "Quality control and conduct of genome-wide association meta-analyses." Nat Protoc. 2014;9(5):1192-212.
Naj AC, Lin H, Vardarajan BN, et al. "Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer's disease sequencing project." Genomics. 2019;111(4):808-818.
Blecker S, Agarwal SK, Chang PP, et al. "Quality of care for heart failure patients hospitalized for any cause." J Am Coll Cardiol. 2014;63(2):123-30.
Merino J, Guasch-Ferré M, Ellervik C, et al. "Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis." BMJ. 2019;366:l4292.
Shafi T, Zhu X, Lirette ST, et al. "Quantifying Individual-Level Inaccuracy in Glomerular Filtration Rate Estimation : A Cross-Sectional Study." Ann Intern Med. 2022;175(8):1073-1082.
Gordon AS, Tabor HK, Johnson AD, et al. "Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset." Hum Mol Genet. 2014;23(8):1957-63.
Muallem H, North KE, Kakoki M, et al. "Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study." Hum Genet. 2007;121(3-4):421-31.
Song J, Chen F, Campos M, et al. "Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects." PLoS One. 2015;10(8):e0132626.
Schreiner PJ, Heiss G, Tyroler HA, Morrisett JD, Davis CE, Smith R. "Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study." Arterioscler Thromb Vasc Biol. 1996;16(3):471-8.
Vollmer WM, Enright PL, Pedula KL, et al. "Race and gender differences in the effects of smoking on lung function." Chest. 2000;117(3):764-72.
Chandra A, Skali H, Claggett B, et al. "Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure." J Am Coll Cardiol. 2022;79(4):355-368.
Zhang Z-M, Rautaharju PM, Prineas RJ, et al. "Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 2016;133(22):2141-8.
Rautaharju PM, Zhang Z-M, Haisty WK, et al. "Race- and sex-associated differences in rate-adjusted QT, QTpeak, ST elevation and other regional measures of repolarization: the Atherosclerosis Risk in Communities (ARIC) Study." J Electrocardiol. 2014;47(3):342-50.
Hicks CW, Daya NR, Black JH, Matsushita K. "Race and sex-based disparities associated with carotid endarterectomy in the Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2020;292:10-16.
Yatsuya H, Folsom AR, Yamagishi K, North KE, Brancati FL, Stevens J. "Race- and sex-specific associations of obesity measures with ischemic stroke incidence in the Atherosclerosis Risk in Communities (ARIC) study." Stroke. 2010;41(3):417-25.
Lutsey PL, Michos ED, Misialek JR, et al. "Race and Vitamin D Binding Protein Gene Polymorphisms Modify the Association of 25-Hydroxyvitamin D and Incident Heart Failure: The ARIC (Atherosclerosis Risk in Communities) Study." JACC Heart Fail. 2015;3(5):347-356.
Chen TK, Coresh JJ, Daya N, Ballew SH, Tin A, Crews DC. "Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study." J Am Geriatr Soc. 2020.
Evans K, Coresh J, Bash LD, et al. "Race differences in access to health care and disparities in incident chronic kidney disease in the US." Nephrol Dial Transplant. 2011;26(3):899-908.
Chen Y, Sang Y, Ballew SH, et al. "Race, Serum Potassium, and Associations With ESRD and Mortality." Am J Kidney Dis. 2017;70(2):244-251.
Reis JP, Michos ED, Selvin E, Pankow JS. "Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Clin Nutr. 2015;101(6):1232-40.
Williams JE, Couper DJ, Din-Dzietham R, Nieto JF, Folsom AR. "Race-gender differences in the association of trait anger with subclinical carotid artery atherosclerosis: the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2007;165(11):1296-304.
Fernandes-Silva MM, Shah AM, Hegde S, et al. "Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC Study." JACC Heart Fail. 2017;5(3):157-165.
Nonterah EA, Crowther NJ, Klipstein-Grobusch K, et al. "Racial and Ethnic Differences in the Association Between Classical Cardiovascular Risk Factors and Common Carotid Intima-Media Thickness: An Individual Participant Data Meta-Analysis." J Am Heart Assoc. 2022;11(15):e023704.
Zakai NA, McClure LA, Judd SE, Safford MM, Folsom AR, Lutsey PL. "Racial and regional differences in venous thromboembolism in the United States in 3 cohorts." Circulation. 2014;129(14):1502-9.
Caughey MC, Vaduganathan M, Arora S, et al. "Racial Differences and Temporal Obesity Trends in Heart Failure with Preserved Ejection Fraction." J Am Geriatr Soc. 2021.
Parrinello CM, Sharrett ARichey, Maruthur NM, Bergenstal RM, Grams ME, Coresh JJ. "Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia." Diabetes Care. 2016;39(4):589-95.
Negi SI, Pankow JS, Fernstrom K, et al. "Racial differences in association of elevated interleukin-18 levels with type 2 diabetes: the Atherosclerosis Risk in Communities study." Diabetes Care. 2012;35(7):1513-8.
Magnani JW, Norby FL, Agarwal SK, Soliman EZ, Chen LYee, Loehr LR. "Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study." JAMA Cardiol. 2016;1(4):433-41.
Gupta DK, Claggett B, Wells Q, et al. "Racial differences in circulating natriuretic peptide levels: the atherosclerosis risk in communities study." J Am Heart Assoc. 2015;4(5).
Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. "Racial differences in glycemic markers: a cross-sectional analysis of community-based data." Ann Intern Med. 2011;154(5):303-9.
Maynard JW, McAdams-Demarco MA, Law A, Kao L, Gelber AC, Coresh JJ. "Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2014;179(5):576-83.
Lewis AA, Ayers CR, Selvin E, et al. "Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study." Circulation. 2020;141(12):957-967.
Naorungroj S, Slade GD, Divaris K, Heiss G, Offenbacher S. "Racial differences in periodontal disease and 10-year self-reported tooth loss among late middle-aged and older adults: the dental ARIC study." J Public Health Dent. 2017;77(4):372-382.
Qiao Y, Suri FK, Zhang Y, et al. "Racial Differences in Prevalence and Risk for Intracranial Atherosclerosis in a US Community-Based Population." JAMA Cardiol. 2017;2(12):1341-1348.
Hutchinson RG, Watson RL, Davis CE, et al. "Racial differences in risk factors for atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities." Angiology. 1997;48(4):279-90.
Zhao D, Post WS, Blasco-Colmenares E, et al. "Racial Differences in Sudden Cardiac Death." Circulation. 2019;139(14):1688-1697.
Lacy ME, Wellenius GA, Carnethon MR, et al. "Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA Study." Diabetes Care. 2016;39(2):285-91.
Wong T Y, Klein R, Duncan BB, et al. "Racial differences in the prevalence of hypertensive retinopathy." Hypertension. 2003;41(5):1086-91.
Mathews L, Ding N, Sang Y, et al. "Racial Differences in Trends and Prognosis of Guideline-Directed Medical Therapy for Heart Failure with Reduced Ejection Fraction: the Atherosclerosis Risk in Communities (ARIC) Surveillance Study." J Racial Ethn Health Disparities. 2022.
Williams JE, Massing M, Rosamond WD, Sorlie PD, Tyroler HA. "Racial disparities in CHD mortality from 1968-1992 in the state economic areas surrounding the ARIC study communities. Atherosclerosis Risk in Communities." Ann Epidemiol. 1999;9(8):472-80.
Nadruz W, Claggett B, Henglin M, et al. "Racial Disparities in Risks of Stroke." N Engl J Med. 2017;376(21):2089-2090.
Ding J, Diez Roux AV, Nieto JF, et al. "Racial disparity in long-term mortality rate after hospitalization for myocardial infarction: the Atherosclerosis Risk in Communities study." Am Heart J. 2003;146(3):459-64.
Deal JA, Albert MS, Arnold M, et al. "A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: Results from the Aging and Cognitive Health Evaluation in Elders Pilot Study." Alzheimers Dement (N Y). 2017;3(3):410-415.
Auer PL, Nalls M, Meschia JF, et al. "Rare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke: The NHLBI Exome Sequence Project." JAMA Neurol. 2015;72(7):781-8.
Sadler B, Haller G, Antunes L, et al. "Rare and duplications containing in clubfoot." J Med Genet. 2020;57(12):851-857.
Marouli E, Graff M, Medina-Gomez C, et al. "Rare and low-frequency coding variants alter human adult height." Nature. 2017;542(7640):186-190.
Huffman JE, de Vries PS, Morrison AC, et al. "Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF." Blood. 2015;126(11):e19-29.
Kapoor A, Bakshy K, Xu L, et al. "Rare coding TTN variants are associated with electrocardiographic QT interval in the general population." Sci Rep. 2016;6:28356.
Lunetta KL, Day FR, Sulem P, et al. "Rare coding variants and X-linked loci associated with age at menarche." Nat Commun. 2015;6:7756.
Nandakumar P, Lee D, Richard MA, et al. "Rare coding variants associated with blood pressure variation in 15 914 individuals of African ancestry." J Hypertens. 2017;35(7):1381-1389.
Choi SHoan, Jurgens SJ, Haggerty CM, et al. "Rare Coding Variants Associated With Electrocardiographic Intervals Identify Monogenic Arrhythmia Susceptibility Genes: A Multi-Ancestry Analysis." Circ Genom Precis Med. 2021;14(4):e003300.
Hindy G, Dornbos P, Chaffin MD, et al. "Rare coding variants in 35 genes associate with circulating lipid levels-A multi-ancestry analysis of 170,000 exomes." Am J Hum Genet. 2022;109(1):81-96.
Sims R, van der Lee SJ, Naj AC, et al. "Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease." Nat Genet. 2017;49(9):1373-1384.
He KY, Kelly TN, Wang H, et al. "Rare coding variants in RCN3 are associated with blood pressure." BMC Genomics. 2022;23(1):148.
Yu B, Pulit SL, Hwang S-J, et al. "Rare Exome Sequence Variants in CLCN6 Reduce Blood Pressure Levels and Hypertension Risk." Circ Cardiovasc Genet. 2016;9(1):64-70.
Rosenthal EA, Shirts BH, Amendola LM, et al. "Rare loss of function variants in candidate genes and risk of colorectal cancer." Hum Genet. 2018;137(10):795-806.
Olfson E, Saccone NL, Johnson EO, et al. "Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans." Mol Psychiatry. 2016;21(5):601-7.
Kan M, Auer PL, Wang GT, et al. "Rare variant associations with waist-to-hip ratio in European-American and African-American women from the NHLBI-Exome Sequencing Project." Eur J Hum Genet. 2016;24(8):1181-7.
Zanoni P, Khetarpal SA, Larach DB, et al. "Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease." Science. 2016;351(6278):1166-71.
Yazdani A, Yazdani A. "Rare variants analysis using penalization methods for whole genome sequence data." BMC Bioinformatics. 2015;16:405.
Loomis SJ, Köttgen A, Li M, et al. "Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study." Sci Rep. 2019;9(1):5941.
Mammen AL, Pak K, Williams EK, et al. "Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects." Arthritis Care Res (Hoboken). 2012;64(2):269-72.
Gornel DL. "Rates of death from coronary heart disease." N Engl J Med. 1999;340(9):730; author reply 731-2.
Shah AM, Cheng S, Skali H, et al. "Rationale and design of a multicenter echocardiographic study to assess the relationship between cardiac structure and function and heart failure risk in a biracial cohort of community-dwelling elderly persons: the Atherosclerosis Risk in Communities stud." Circ Cardiovasc Imaging. 2014;7(1):173-81.